Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Research question (s)/hypothesis:
- . The effectiveness of the shared care management of gestational diabetes mellitus;
- . The cost-effectiveness of the shared care management;
- . Its sustainability
| Condition | Intervention |
|---|---|
|
Gestational Diabetes Mellitus |
Behavioral: Shared glycaemic control care within the local three-tier's antenatal care network |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention |
| Official Title: | A Randomized Translational Study to Examine the Effects of Shared Care Versus Usual Care in Management of Gestational Diabetes in a Three-tier Prenatal Care Network in Tianjin, China |
- The rate of macrosomia. [ Time Frame: At the time of birth. ] [ Designated as safety issue: No ]Macrosomia is defined as birthweight ≥ 4000 gram.
- The rate of pregnancy-induced hypertension. [ Time Frame: From enrolment at 24-28 gestational weeks till after delivery, an average of 12 weeks. ] [ Designated as safety issue: No ]Pregnancy-induced hypertension includes gestational hypertension and preeclampsia/eclampsia.
| Estimated Enrollment: | 920 |
| Study Start Date: | September 2010 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: The usual care arm |
Behavioral: Shared glycaemic control care within the local three-tier's antenatal care network
Other Name: The shared lifestyle intervention arm
|
| Active Comparator: The shared care arm |
Behavioral: Shared glycaemic control care within the local three-tier's antenatal care network
Other Name: The shared lifestyle intervention arm
|
Detailed Description:
Method (s) Tianjin three-tier antenatal care network established a universal screening program for gestational diabetes mellitus (GDM) in 1998 and up to 2008, the screening program had screened 115348 pregnant women. GDM will be defined as either fasting plasma glucose (PG) ≥5.1 mmol/L or 1-hour PG≥ 10.0 mmol/L or 2-hour PG≥ 8.5 mmol/L after 75 g glucose tolerance test. A total of 920 pregnant women who have GDM and agree to participate will be randomly assign to have the shared care (diet, physical activity and insulin if indicated) or the local usual antenatal care. The sample size has ≥80% power at a 5% type I error to detect the difference in the primary endpoint, birth weight ≥4000 gram and the secondary endpoint, pregnancy-induced hypertension. Hyperglycemia and other clinical data in the two groups of women will be collected during the shared care or the usual care. Logistic regression and cost-effectiveness analysis will be used in the data analysis.
Public health significance: The introduction of the proven management of GDM in Tianjin antenatal care network will justify the universal screening for GDM and reduce the rate of macrosomic infants and reduce pregnancy-induced hypertension, and thus improve pregnancy outcomes of women with GDM.
Sustainability plan: Just as the universal GDM screening in 1998, the shared care model will be introduced into the Tianjin antenatal care network as part of the usual care routine after the proposed study. The success of the care model will also be publicized and expanded to suburban districts and rural counties of Tianjin, possibly other parts of world where universal screening for GDM is a routine practice.
ACKNOWLEDGEMENT This project is supported by a BRIDGES grant from the International Diabetes Federation. BRIDGES, an International Diabetes Federation project, is supported by an educational grant from Lilly Diabetes."
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All pregnant women who are diagnosed to have GDM.
Exclusion Criteria:
- Diagnosis of overt diabetes during OGTT;
- Younger than 18 years of age;
- Non-singleton pregnancy;
- Maternal-foetal ABO blood type incompatibility;
- Maternal diseases such as chronic hypertension,thyrotoxicosis, prepregnancy diabetes and use of long-term medications that may affect glucose metabolism.
Contacts and Locations| Contact: Cuiping Zhang, MPH,MD | +86 2258297936 | zcpyly@126.com |
| China, Tianjin | |
| Tianjin Women and Children's Health Center | Recruiting |
| Tianjin, Tianjin, China | |
| Contact: Cuiping Zhang, MPH MD +86 2258297936 zcpyly@126.com | |
| Principal Investigator: Huiguang Tian, MPH PHD | |
| Principal Investigator: Xilin Yang, PHD | |
| Study Chair: | Gongshu Liu, MD | Women and Children's Health Center |
More Information
No publications provided
| Responsible Party: | Tianjin Women and Children's Health Center |
| ClinicalTrials.gov Identifier: | NCT01565564 History of Changes |
| Other Study ID Numbers: | 2009-02 |
| Study First Received: | March 21, 2012 |
| Last Updated: | December 6, 2012 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Tianjin Women and Children's Health Center:
|
Gestational diabetes mellitus intervention shared care |
pregnancy outcome macrosomia pregnancy-induced hypertension |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes, Gestational Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Pregnancy Complications |
ClinicalTrials.gov processed this record on May 21, 2013